Glucose, Needle-Free Vaccines Hold Promise For Sontra Ultrasound Device
This article was originally published in The Pink Sheet Daily
Executive Summary
Sontra Medical’s SonoPrep ultrasonic skin permeation system clinical studies for vaccine, large molecule drug delivery planned for later this year, CEO Davison says. The diagnostic and drug-delivery firm also is developing a blood glucose monitoring system in partnership with Bayer.
You may also be interested in...
Iressa Eyed As Worthy Drug Candidate For Companion Diagnostic
AstraZeneca maintains a "laissez-faire" approach to an Iressa lung cancer drug/diagnostic combination, DxS CEO Little says. Genzyme asserts use of DakoCytoMation's HercepTest in the pivotal study would have sped FDA approval of Herceptin.
“Primary Mode Of Action” Reg To Facilitate Review Center Assignment Of Combo Products
FDA’s proposed rule defines primary mode as “the single mode of action of a combination product that provides the most important therapeutic action of the combination product.”